Pathogenesis of pulmonary emphysema – cellular and molecular events

Pathogenesis of pulmonary emphysema – cellular and molecular events

Show other versions (1)

ABSTRACT Pulmonary emphysema is a chronic obstructive disease, resulting from important alterations in the whole distal structure of terminal bronchioles, either by enlargement of air spaces or by destruction of the alveolar wall, leading to loss of respiratory surface, decreased elastic recoil and...

Full description

Bibliographic Details
Main Author:	Antonio Di Petta
Format:	Article
Language:	English
Published:	Instituto Israelita de Ensino e Pesquisa Albert Einstein 2010-06-01
Series:	Einstein (São Paulo)
Subjects:	Pulmonary emphysema Alpha 1-antitrypsin Oxidative stress Apoptosis Cell aging
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082010000200248&tlng=en

Similar Items

Pathogenesis of pulmonary emphysema – cellular and molecular events
by: Antonio Di Petta
Published: (2010-06-01)

Emphysema and COPD in a young woman
by: Kevin Conroy, et al.
Published: (2014-01-01)

Alpha-1 Antitrypsin Gene Variants in Patients without Severe Deficiency Diagnosed with Pulmonary Emphysema on Chest CT
by: Laviña E, et al.
Published: (2024-02-01)

Short-term variability of biomarkers of proteinase activity in patients with emphysema associated with type Z alpha-1-antitrypsin deficiency
by: Nieuwenhuizen Willem, et al.
Published: (2005-05-01)

Acute Disseminated Panniculitis Associated with Alpha-1 Antitrypsin Deficiency
by: António Guilherme Murinello, et al.
Published: (2022-10-01)

Case report of a novel alpha1-antitrypsin null variant in Türkiye: Q0RİZE
by: Dilek Karadoğan, et al.
Published: (2024-02-01)

The patient profile of individuals with Alpha-1 antitrypsine gene mutations at a referral center in Brazil
by: Manuela Brisot Felisbino, et al.

Cellular Consequences of Z Alpha-1 Antitrypsin Accumulation and Prospects for Therapy
by: Sam Alam, et al.
Published: (2013-12-01)

Alpha-1 antitrypsin: now available, but do we need it?
by: Swiss Medical Weekly
Published: (2008-04-01)

Unique and shared systemic biomarkers for emphysema in Alpha-1 Antitrypsin deficiency and chronic obstructive pulmonary disease
by: K.A. Serban, et al.
Published: (2022-10-01)

Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence
by: Franck F. Rahaghi, et al.
Published: (2017-05-01)

Description of a new rare alpha-1 antitrypsin mutation in Naples (Italy): PI*M S-Napoli
by: Marco Mosella, et al.
Published: (2018-01-01)

Alpha-1 Antitrypsin Screening in a Selected Cohort of Patients Affected by Chronic Pulmonary Diseases in Naples, Italy
by: Anna Annunziata, et al.
Published: (2021-04-01)

Alpha- 1 Antitrypsin Deficiency in Children: Pulmonary Involvement
by: Mohammad Esmaeili, et al.
Published: (2015-02-01)

Prevalence of genetic mutations in alpha-1 antitrypsin deficiency (aatd) in patients with chronic obstructive pulmonary disease in Colombia
by: Abraham Alí-Munive, et al.
Published: (2023-05-01)

No gender-specific differences in comorbidities in patients with chronic obstructive pulmonary disease due to alpha-1 antitrypsin deficiency
by: Josef Yayan, et al.
Published: (2023-11-01)

The prevalence of bronchiectasis in patients with alpha-1 antitrypsin deficiency: initial report of EARCO
by: Robert A. Stockley, et al.
Published: (2023-08-01)

Treatment of lung disease in alpha-1 antitrypsin deficiency: a systematic review
by: Edgar RG, et al.
Published: (2017-05-01)

Gene and miRNA expression profiles in PBMCs from patients with severe and mild emphysema and PiZZ alpha1-antitrypsin deficiency
by: Esquinas C, et al.
Published: (2017-11-01)

In Vivo Electroporation-Mediated, Intrahepatic Alpha1 Antitrypsin Gene Transfer Reduces Pulmonary Emphysema in Pallid Mice
by: Marco A. Sutter, et al.
Published: (2020-08-01)

Pulmonary emphysema and atherosclerosis: association or syndrome?
by: Atef W. Elrefai, et al.
Published: (2020-10-01)

Characterization of three new SERPINA1 variants PiQ0Heidelberg II, PiQ0Heidelberg III and PiQ0Heidelberg IV in patients with severe alpha-1 antitrypsin deficiency
by: Philipp Höger, et al.
Published: (2023-01-01)

Alpha-1 antitrypsin gene polymorphism in Chronic Obstructive Pulmonary Disease (COPD)
by: Sabri Denden, et al.
Published: (2010-01-01)

Identification of a rare p.G320R alpha-1-antitrypsin variant in emphysema and lung cancer patients
by: Mila Ljujic, et al.
Published: (2010-01-01)

The impact of emphysema in pulmonary fibrosis
by: Vincent Cottin
Published: (2013-06-01)

Enfisema bulloso bilateral gigante por déficit de alfa1-antitripsina Giant bilateral bullous emphysema due to deficit of alpha1-antritypsin
by: Armando Leal Mursulí, et al.
Published: (2009-03-01)

Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications
by: Chapman KR, et al.
Published: (2018-01-01)

Severe Nocardia pneumonia in an immunocompromised patient with alpha‐1 antitrypsin deficiency
by: Daryl E. C. Y. Chan, et al.
Published: (2020-11-01)

Individualized lung function trends in alpha-1-antitrypsin deficiency: a need for patience in order to provide patient centered management?
by: Stockley RA, et al.
Published: (2016-08-01)

Approach to: Chronic obstructive pulmonary disease (COPD)
by: Alexander Ni
Published: (2020-10-01)

Association between circulating alpha-1 antitrypsin polymers and lung and liver disease
by: Alexa Núñez, et al.
Published: (2021-09-01)

Expert Perspectives on the Management of Alpha 1-Antitrypsin Deficiency
by: Bebiana Conde, et al.
Published: (2022-07-01)

Protease-Specific Biomarkers to Analyse Protease Inhibitors for Emphysema Associated with Alpha 1-Antitrypsin Deficiency. An Overview of Current Approaches
by: Simona Viglio, et al.
Published: (2021-01-01)

Baseline characteristics from a 3-year longitudinal study to phenotype subjects with COPD: the FOOTPRINTS study
by: James D. Crapo, et al.
Published: (2023-11-01)

Therapeutic benefits of recombinant alpha1-antitrypsin IgG1 Fc-fusion protein in experimental emphysema
by: Katsuyuki Takeda, et al.
Published: (2021-07-01)

PROINFLAMMATORY CYTOKINE PROFILE IN PATIENTS WITH DIFFERENT ALPHA-1-ANTITRYPSIN PHENOTYPES
by: M. Yu. Pervakova, et al.
Published: (2016-12-01)

Intralobar pulmonary sequestration masquerading as congenital lobar emphysema
by: Bilal Mirza, et al.
Published: (2011-01-01)

Cardiovascular risk in patients with alpha-1-antitrypsin deficiency
by: Sebastian Fähndrich, et al.
Published: (2017-09-01)

Clinical utility of alpha-1 proteinase inhibitor in the management of adult patients with severe alpha-1 antitrypsin deficiency: a review of the current literature
by: Parr DG, et al.
Published: (2017-07-01)

Combined Pulmonary Fibrosis and Emphysema: A Case Report and Literature Review
by: Shaghayegh Badriahmadi, et al.
Published: (2021-03-01)